|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,116.84 |
3.28% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$65,550.90 |
3.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$54,927.00 |
2.57% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$53,145.05 |
2.49% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$51,844.40 |
2.43% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$49,179.33 |
2.30% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$47,623.12 |
2.23% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$47,377.13 |
2.22% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,164.70 |
2.21% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,908.00 |
2.20% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$46,631.87 |
2.18% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,651.81 |
2.14% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$45,709.24 |
2.14% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,421.53 |
2.13% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$45,111.74 |
2.11% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$44,884.08 |
2.10% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,538.14 |
2.09% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$44,624.83 |
2.09% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,468.97 |
2.08% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,286.91 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$44,195.77 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,531.88 |
2.04% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,719.57 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,080.06 |
1.97% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$41,889.34 |
1.96% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,682.70 |
1.95% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$41,567.34 |
1.95% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$40,716.72 |
1.91% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$40,786.03 |
1.91% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,103.52 |
1.88% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$39,609.80 |
1.86% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$39,103.90 |
1.83% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,091.86 |
1.83% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$38,827.46 |
1.82% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,910.82 |
1.82% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,639.03 |
1.81% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,695.20 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,221.87 |
1.79% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,554.09 |
1.76% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$37,499.44 |
1.76% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$36,788.37 |
1.72% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$36,692.80 |
1.72% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,761.72 |
1.72% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,704.05 |
1.67% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,802.80 |
1.63% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$34,456.37 |
1.61% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$33,918.49 |
1.59% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$32,739.77 |
1.53% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,871.28 |
1.49% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$27,529.39 |
1.29% |
| US Dollar |
$USD |
|
2,704 |
$2,704.37 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|